• 4/7/2021

BioSens8 was awarded the second largest prize at the M2D2 $200K Challenge! We're thrilled to be supported by M2D2 with a cash award! Check out our award winning pitch.

• 4/7/2021

BioSens8 pitched in front of a panel of Med Tech judges including industry leaders, investors, and practitioners for the BU Ignition Award!

• 4/5/2021

BioSens8 successfully submitted a NIH STTR Phase I application!

• 3/8/2021

BioSens8 was selected as a M2D2 $200K Finalist! We were one of 15 startups (out of more than 170 worldwide entrants) in the running for $200,000 in in-kind services and research support from sponsors that include UMass Lowell, Amgen, Boston Scientific, Johnson & Johnson Innovation, Massachusetts Life Sciences Center, Mintz, and others.

The virtual M2D2 $200K Challenge Finalist Pitch-off being hosted through Zoom on Wednesday, March 24^th. Register for free and watch us pitch here!

• 3/4/2021

BioSens8 successfully submitted a NSF STTR Phase I application!

• 2/11/2021

BioSens8 was selected as an Ignition Award finalist! Our full proposal was well received by the Ignition Review Committee, made up of outside representatives (investors, industry) and BU academics. As a finalist, BioSens8 will present for the Ignition Award on 4/7/2021!

• 12/16/2020

BioSens8 officially incorporated!

• 11/23/2020

BioSens8 was selected to submit a full proposal for the Boston University Ignition Award of $75K! The Ignition Award program is designed to help Boston University researchers bring their projects with commercial potential to the next level.